07:00 , Jul 19, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Osteoarthritis Guanine nucleotide binding protein-like 3 (GNL3; nucleostemin) Genomewide association studies identified mutations in the GNL3 gene that could help...
07:00 , Sep 17, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Brain cancer Guanine nucleotide binding protein-like 3 (GNL3; nucleostemin) Imaging studies in mice suggest that targeting tumors with high levels of nucleostemin could help...
07:00 , Apr 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Bipolar disorder Inter-alpha trypsin inhibitor heavy chain 1 (ITIH1); Inter-alpha trypsin inhibitor heavy chain 3 (ITIH3); guanine nucleotide binding protein-like-3 (GNL3);...